---
title: "Revelation Biosciences, Inc. (REVB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/REVB.US.md"
symbol: "REVB.US"
name: "Revelation Biosciences, Inc."
industry: "生物技术"
---

# Revelation Biosciences, Inc. (REVB.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.revbiosciences.com](https://www.revbiosciences.com) |

## Company Profile

Revelation Biosciences, Inc. 是一家临床阶段的生物制药公司，专注于免疫系统治疗和诊断的开发与商业化。它从事治疗产品候选药物的开发，包括 GEM-AKI，一种潜在的急性肾损伤预防和治疗疗法；以及 GEM-CKD，一种潜在的慢性肾病预防和治疗疗法。该公司之前被称为 Petra Acquisition, Inc

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.15 | 90/605 | - | - | - |
| PB | 0.20 | 9/605 | 0.95 | 0.59 | 0.48 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-29T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.47 |
| Highest Target | 90.00 |
| Lowest Target | 80.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/REVB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/REVB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/REVB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.